Protagenic Therapeutics Balance Sheet Health
Financial Health criteria checks 4/6
Protagenic Therapeutics has a total shareholder equity of $719.0K and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $1.5M and $789.3K respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$1.06m |
| Equity | US$719.01k |
| Total liabilities | US$789.32k |
| Total assets | US$1.51m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: PTIX's short term assets ($1.4M) exceed its short term liabilities ($789.3K).
Long Term Liabilities: PTIX has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: PTIX is debt free.
Reducing Debt: PTIX had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: PTIX has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: PTIX has less than a year of cash runway if free cash flow continues to reduce at historical rates of 30.3% each year